Express the truth to gain the trust

Key Topics

Late biocompatibility is now the next challenge for DES technology: what is the scope of the problem? Do we know the clinical impact? How can we manage this issue with existing solutions?
5 questions to the experts
5 burning questions from Dr Chevalier about DES safety: a matter of controversy?

See what Dr Morice and Dr Wijns have to say and react to their answers.		 Dr Wijns Dr Morice Dr Chevalier

Clinical Video
Stent thrombosis is one of the major limitation of left main PCI in the DES era : this case is a typical example of current real dilemma

Operator: M. Gick, K. Werner
A live case from Herz-Zentrum Bad Krozingen (38 min.)

 Clinical Case Clinical Case

Lectures
• The mechanisms: Insights from pathology with Dr R Virmani

Past predictions, current perspectives, future forecasts of drug-eluting stents: the view of the pathologist
R. Virmani


• The impact of safety?

Safety profile of DES
A. Bartorelli


• DES for all : a controversy between William O’Neil and Antonio Colombo

Debate: DES for all patients and all lesions - Pro: universal use strategy
A. Colombo
Debate: DES for all patients and all lesions - Contra: selective use strategy
W. O'Neill


• The precautionary attitude

Precautionary attitude before widespread use of DES
J. Marco

Related papers in Eurointervention
FDA panel, 7 and 8 December 2006 - The impact on our practice and research
P.W. Serruys		 EuroIntervention 8th Issue

To consult other topics, click here.


Back